Skip to main content
Image coming soon

Risk-Managed AI in Pharmaceutical R&D Operations for Compliance Officers

$199.00
Adding to cart… The item has been added

A tailored course, built for your situation

Risk-Managed AI in Pharmaceutical R&D Operations for Compliance Officers

Implement AI governance with precision in regulated drug development environments

$199 one-time
24-hour access provisioning 30-day money-back guarantee Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
AI is accelerating drug discovery, but compliance teams face increasing scrutiny without clear implementation frameworks.

The situation this course is for

Compliance officers are being asked to assess AI-driven R&D activities they weren’t trained to evaluate. Traditional oversight models don’t address dynamic model behavior, data provenance in machine learning pipelines, or audit readiness for adaptive algorithms. This creates friction, delays, and uncertainty.

Who this is for

Compliance, risk, or quality assurance professionals in biopharma or CROs who need to govern AI-enabled R&D with technical precision and regulatory confidence.

Who this is not for

This is not for data scientists without regulatory responsibilities, entry-level compliance staff without R&D exposure, or professionals outside life sciences.

What you walk away with

  • Apply risk-based AI governance aligned with FDA and EMA expectations
  • Integrate AI validation into existing GxP quality systems
  • Lead cross-functional assessments of AI-driven development workflows
  • Document compliance justifications for algorithmic decision-making
  • Anticipate regulatory questions and prepare audit-ready evidence packages

The 12 modules (with all 144 chapters)

Module 1. AI in Regulated Pharmaceutical Development
Understand how AI is transforming drug discovery and development workflows within compliance-bound environments.
12 chapters in this module
  1. The rise of AI in target identification
  2. Key differences between traditional and AI-driven R&D
  3. Regulatory posture across FDA, EMA, and PMDA
  4. AI use cases in preclinical development
  5. Clinical trial design powered by machine learning
  6. Emerging norms in model transparency
  7. Compliance officer as innovation enabler
  8. Balancing speed and oversight
  9. Case study: AI in toxicology prediction
  10. Defining the scope of AI governance
  11. Stakeholder mapping in AI projects
  12. Setting expectations for audit readiness
Module 2. Regulatory Foundations for AI Oversight
Map current guidance to practical compliance requirements for AI systems.
12 chapters in this module
  1. ICH Q9 principles applied to AI
  2. GxP applicability to machine learning models
  3. Data integrity in AI training pipelines
  4. ALCOA+ for algorithmic outputs
  5. 21 CFR Part 11 in AI contexts
  6. Annex 11 equivalencies for model deployment
  7. Inspectors’ growing focus on model behavior
  8. How regulators interpret 'validation'
  9. Precedents from recent warning letters
  10. Risk ranking AI components
  11. Establishing AI system boundaries
  12. Documentation standards for audit trails
Module 3. Risk-Based AI Governance Frameworks
Adopt scalable governance models tailored to AI risk levels in R&D.
12 chapters in this module
  1. Defining risk tiers for AI applications
  2. Mapping AI use cases to risk categories
  3. Governance committee structures
  4. Escalation paths for model anomalies
  5. Thresholds for compliance intervention
  6. Lifecycle oversight from prototype to production
  7. Version control and model lineage
  8. Change impact assessments
  9. Model revalidation triggers
  10. Human-in-the-loop requirements
  11. Third-party AI oversight
  12. Vendor risk in AI partnerships
Module 4. AI Model Validation for Compliance
Apply validation principles to machine learning models in drug development.
12 chapters in this module
  1. Validation vs. verification in AI
  2. Defining model performance criteria
  3. Establishing acceptance thresholds
  4. Test data strategy for training sets
  5. Bias detection in biological datasets
  6. Model interpretability techniques
  7. Sensitivity analysis for algorithmic outputs
  8. Prospective validation planning
  9. Ongoing monitoring requirements
  10. Handling model drift in clinical contexts
  11. Documentation for validation reports
  12. Audit preparation for model reviews
Module 5. Data Governance in AI-Driven R&D
Ensure data quality and provenance across AI training and inference.
12 chapters in this module
  1. Data sourcing in regulated research
  2. Metadata requirements for model inputs
  3. Provenance tracking in pipelines
  4. Handling real-world data in AI
  5. Data anonymization and privacy
  6. Data lineage tools and practices
  7. Versioning training datasets
  8. Data quality dashboards
  9. Handling missing or corrupted data
  10. Audit trails for data transformations
  11. Data access controls in AI workflows
  12. Data retention in model lifecycle
Module 6. Change Management for AI Systems
Integrate AI updates into formal change control processes.
12 chapters in this module
  1. Defining change scope for AI models
  2. Impact assessment templates
  3. Approval workflows for model updates
  4. Versioning strategy for AI artifacts
  5. Rollback planning for AI failures
  6. Communication plans for AI changes
  7. Training needs for updated models
  8. Post-deployment monitoring
  9. Incident response for AI anomalies
  10. Documenting change history
  11. Audit readiness for change logs
  12. Best practices from leading pharma
Module 7. Audit Readiness for AI Applications
Prepare for inspections with clear, compliant AI documentation.
12 chapters in this module
  1. Inspection trends in AI governance
  2. Common findings in AI audits
  3. Preparing AI system dossiers
  4. Model validation evidence packs
  5. Interview readiness for compliance teams
  6. Handling inspector questions on AI
  7. Documenting risk assessments
  8. Evidence of ongoing monitoring
  9. Training records for AI oversight
  10. Cross-functional alignment proofs
  11. Regulatory correspondence tracking
  12. Mock audit simulations
Module 8. Ethical Oversight of AI in Drug Development
Integrate ethical review into AI governance frameworks.
12 chapters in this module
  1. Bias in clinical trial recruitment models
  2. Fairness in patient selection algorithms
  3. Transparency in AI decision-making
  4. Patient autonomy and AI recommendations
  5. Ethics committee engagement
  6. Informed consent in AI-augmented trials
  7. Dual-use concerns in AI research
  8. Global variations in ethics standards
  9. Public trust in AI-driven discovery
  10. Handling unexpected AI outputs
  11. Ethical escalation pathways
  12. Documentation of ethical reviews
Module 9. Cross-Functional Collaboration Models
Lead effective collaboration between compliance, data science, and R&D teams.
12 chapters in this module
  1. Bridging compliance and technical teams
  2. Translating regulatory needs to engineers
  3. Facilitating joint risk assessments
  4. Conflict resolution in AI projects
  5. Compliance role in agile environments
  6. Sprint planning with oversight
  7. Joint documentation practices
  8. Shared definitions of 'ready'
  9. Feedback loops for model improvement
  10. Building trust across functions
  11. Case study: AI in biomarker discovery
  12. Governance in decentralized teams
Module 10. AI in Clinical Trial Operations
Govern AI applications in trial execution and monitoring.
12 chapters in this module
  1. AI for site selection and recruitment
  2. Predictive enrollment modeling
  3. Adverse event prediction models
  4. Risk-based monitoring powered by AI
  5. Centralized data review with AI
  6. Compliance with ICH E6(R3) drafts
  7. Oversight of AI-driven monitoring
  8. Validation of trial analytics
  9. Data privacy in AI trial tools
  10. Patient-facing AI in trials
  11. Audit trails for AI trial decisions
  12. Inspection readiness for trial AI
Module 11. Global Regulatory Strategy for AI
Navigate international differences in AI oversight expectations.
12 chapters in this module
  1. FDA AI/ML Action Plan implications
  2. EMA’s AI roadmap for medicines
  3. PMDA guidance on AI in submissions
  4. Health Canada’s adaptive pathways
  5. MHRA’s innovation office insights
  6. China NMPA AI expectations
  7. Harmonization efforts via ICH
  8. Local adaptation requirements
  9. Submission strategies for AI components
  10. Labeling considerations for AI
  11. Post-market surveillance for AI
  12. Global inspection trends
Module 12. Future-Proofing Compliance for AI Innovation
Lead the evolution of compliance in an AI-driven R&D landscape.
12 chapters in this module
  1. Anticipating next-gen AI technologies
  2. Generative AI in drug discovery
  3. Autonomous lab systems oversight
  4. AI in real-world evidence generation
  5. Regulatory sandboxes and pilots
  6. Compliance as innovation partner
  7. Building AI literacy in teams
  8. Succession planning for AI roles
  9. Measuring compliance enablement
  10. Thought leadership pathways
  11. Scaling governance frameworks
  12. Lifelong learning in AI compliance

How this maps to your situation

  • You’re leading oversight in an AI-augmented R&D environment
  • You’re evaluating AI tools for compliance readiness
  • You’re preparing for regulatory inspections involving AI
  • You’re building internal AI governance frameworks

Before vs. after

Before
Uncertain about how to govern AI in R&D, relying on general compliance knowledge without structured AI-specific frameworks.
After
Confidently lead AI governance initiatives, applying proven strategies for validation, audit readiness, and cross-functional collaboration in regulated environments.

What's included with your purchase

  • 12 modules with 12 chapters each (144 chapters)
  • Downloadable templates and worked examples for every module
  • Hand-built implementation playbook delivered alongside course access
  • 30-day money-back guarantee

Delivery and format

  • Course and learning environment access provisioned within 24 hours of purchase
  • Hand-built implementation playbook delivered alongside course access

Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.

Time investment: Approximately 45, 60 hours total, designed for pacing over 8, 12 weeks with flexible access.

If nothing changes
Without structured AI governance skills, compliance professionals risk being sidelined in critical R&D decisions, missing opportunities to shape innovation responsibly and demonstrate leadership in emerging regulatory landscapes.

How this compares to the alternatives

Unlike generic AI ethics courses or technical data science bootcamps, this program is built specifically for compliance officers in pharma, combining regulatory depth with implementation-grade tools used by leading organizations.

Frequently asked

Who is this course designed for?
Compliance, quality, and regulatory professionals in pharmaceutical R&D who need to govern AI applications with confidence and precision.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is there a certificate upon completion?
Yes, a digital certificate of mastery is awarded upon finishing all modules and assessments.
$199 one-time. Approximately 45, 60 hours total, designed for pacing over 8, 12 weeks with flexible access..

Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.

30-day money-back guarantee· 144 chapters· Hand-built playbook included· Account access within 24 hours
!